Harvard Bioscience, Inc. - HBIO - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: May 19, 2013

Harvard Bioscience, Inc. - SIC # 3826

Ticker	Exchange	SIC #	Website	Latest Ticker
HBIO	Nasdaq	3826	http://www.harvardbioscience.com	5.13 -0.03
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: Publicly Traded Company Industry Ratios Publicly Traded Company VS. Industry Ratios Publicly Traded Company VS Publicly Traded Company Private Company VS Publicly Traded Company
Latest Headlines for Harvard Bioscience, Inc. HARVARD BIOSCIENCE INC Financials - May 17th, 2013 11:04 am Finding Investment Opportunities in Quality Growth Health Care Companies That the Rest of the Market is Overlooking - May 17th, 2013 9:04 am HARVARD BIOSCIENCE INC Files SEC form 8-K, Change in Directors or Principal Officers - May 15th, 2013 9:04 pm Harvard Bioscience CEO Graziano will retire - May 15th, 2013 9:26 am Harvard Bioscience CEO Graziano will retire - May 15th, 2013 9:26 am Harvard Bioscience Announces Retirement of CEO and Appointment of Interim CEO - May 15th, 2013 5:30 am HARVARD BIOSCIENCE INC Files SEC form 10-Q, Quarterly Report - May 10th, 2013 3:49 am Short On Oculus: Wound Care Company Has Left Dirty Scars - May 7th, 2013 11:55 am HARVARD BIOSCIENCE INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex - May 7th, 2013 6:08 am Q1 2013 Harvard Bioscience, Inc. Earnings Release - Before Market Open - May 2nd, 2013 5:07 am HBIO Reports First Quarter 2013 Results - May 2nd, 2013 5:00 am HBIO Affirms Plan to Spin-Off Harvard Apparatus Regenerative Technology, Inc. and Announces Its Intended Path Forward - May 1st, 2013 4:35 pm HBIO Affirms Plan to Spin-Off Harvard Apparatus Regenerative Technology, Inc. and Announces Its Intended Path Forward - May 1st, 2013 3:37 pm Webcast Now Available of Press Conference Discussing Landmark Surgery Involving Harvard Bioscience's Synthetic Trachea Scaffold and "InBreath" Bioreactor - Apr 30th, 2013 5:11 pm Photo Release -- Harvard Apparatus Regenerative Technology's "InBreath" Scaffold and Bioreactor Used in First U.S. Transplant of a Regenerated Trachea - Apr 30th, 2013 10:00 am Photo Release -- Harvard Apparatus Regenerative Technology's "InBreath" Scaffold and Bioreactor Used in First U.S. Transplant of a Regenerated Trachea - Apr 30th, 2013 9:00 am Harvard Bioscience to Participate in Press Conference Today to Discuss Landmark Surgery - Apr 30th, 2013 5:00 am Harvard Bioscience, Inc. Schedules First Quarter 2013 Conference Call for May 2, 2013 - Apr 26th, 2013 12:00 pm [video] The Five Dumbest Things on Wall Street: April 12 - Apr 12th, 2013 3:00 am 4 Healthcare Stock Stories for Thursday Investment Wellness - Apr 11th, 2013 10:48 am View All Current Headlines >>